Study | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
---|---|---|---|---|---|---|---|
Fonseca et al25 | Unclear | Low | Low | Low | High | Low | High |
Gilman*26 | Unclear | Unclear | Low | Low | High | Unclear | High |
Abdulwahid*27 | Unclear | Unclear | Low | Low | Unclear | Unclear | Unclear |
Lukashevich*28 | Unclear | Unclear | Low | Low | Low | Low | Unclear |
Makdissi et al29 | Unclear | Unclear | Low | Low | Unclear | Low | Low |
Moses et al*30 | Unclear | Unclear | Low | Low | High | Unclear | Unclear |
Nogueira*31 | Unclear | Unclear | Low | Low | Low | Unclear | Unclear |
Violante et al32 | Unclear | Unclear | Low | Low | High | Low | High |
Owens et al33 | Unclear | Unclear | Low | Low | Low | Low | High |
Hermansen et al34 | Low | Low | Low | Low | High | Unclear | High |
Items:
1. Random sequence generation.
2. Allocation concealment.
3. Blinding of participants and personnel.
4. Blinding of outcome assessment.
5. Incomplete outcome data.
6. Selective reporting.
7. Other bias.
*Unpublished data.
High, high risk; Low, low risk; Unclear, unclear risk.